"After a month of exhaustive coverage of the vaccine scandal in China, the facts of the story have crystallized as have theories about how nearly $90 million worth of expired or improperly stored doses could have reached consumers. But little attention has been paid to Vietnam where a similar scandal is unfolding, albeit on a smaller scale." So starts my column on the supply chain and political problems that make Vietnam a likely candidate for the next country to have a vaccine scandal in East Asia. The column focuses in on the perceived … [Read more...] about Vietnam’s vaccine scandal calls for action
Could the China Vaccine Scandal Impact Vietnam and Neighboring Countries? One of the questions that is driving my analysis of the China vaccine scandal is, Could some of the obvious driving factors that made the scandal possible ever infect neighboring countries? I'll be tackling this and other questions more in depth in a Nikkei Asian Review article next week, but I just want to jot down a few thoughts here on one country of particular concern as far as China's neighbors go, Vietnam. The Vietnam healthcare system has a long list of problems … [Read more...] about China Vaccine Scandal: Could it infect Vietnam?
During a series of interviews, in 2014, Rubicon Strategy Group spoke with country managers of pharmaceutical and device companies, director level administrators in public and private hospitals, successful pharmacy and medical device shop owners, and entrepreneurs at the forefront of the cutting edge in the Vietnam healthcare market. In addition the team went out and conducted a validated survey questionnaire of consumers to judge their preference for particular products, and their preference for healthcare access options in the public and the … [Read more...] about Vietnam Healthcare Firms Struggle Locally (Healthcare Asia)
Led by Damjan Denoble, its primary focus was on how Vietnam’s pharmaceutical market was developing, with particular attention to structural changes around distribution and public hospital tenders, and how these changes were impacting MNC pharma. The research report is available now, and has some interesting findings, particularly around how the tendering process is shaping up. … [Read more...] about Pharmaceutical Tendering In Vietnam
Studying Healthcare in Vietnam Eight months ago I traveled to Ho Chi Minh City and Hanoi to conduct a series of interviews with leading pharmaceutical and device companies. With the gracious support of DKSH Vietnam, the leading local distribution and logistics partner, I was able to interview executives in Santen, Baxter, Aguettant, Ferring, Reckitt Benckiser, Novo Nordisk, Bbraun, J&J Medical, Eisai, 3M, Hanssen Cillag, and Omron, as well as administrators of the 115 Hospital, Cho Ray Hospital, Thanh Do Hospital, Pham Ngoc Thach Hospital, … [Read more...] about Healthcare in Vietnam Report: Pharma, Device, & the Tender Process
The unique ability of doctors to traverse between public and private care settings means that, in effect, doctors become the sole bridge between the public and the private space. Their presence or lack thereof can make or break the launch of a new hospital because the reputation of support staff, even of foreign trained pharmacists for example, is not enough to lure patients. … [Read more...] about Importance of Physicians in Vietnam’s Private Hospitals (LinkedIn)